ADUR · Aduro Clean Technologies Inc.

Aduro Clean Technologies Inc. reported materially higher operating losses for the nine months ended February 28, 2026, consistent with its pre-revenue, capital-intensive development phase. The $14.4M net loss reflects aggressive investment in R&D ($5.9M) and G&A ($8.1M), up 48% and 83% year-over-year respectively, as the company advances its Hydrochemolytic™ platform toward commercialization. Revenue remains immaterial at $167K — derived from early-stage activities — confirming the business is not yet monetizing its technology. Crucially, the company significantly strengthened its balance sheet: cash surged to $39.4M, funded almost entirely by $44.2M in net proceeds from two underwritten U.S. public offerings disclosed in Note 10. This capital infusion enabled a $4.4M increase in property and equipment, supporting pilot-scale infrastructure build-out. Management explicitly states it has sufficient funds to operate for at least twelve months, citing $39.9M working capital and affirming the going concern assumption. The MD&A underscores a strategic pivot toward licensing and royalties — rather than asset-heavy manufacturing — to reduce capital intensity and accelerate commercial adoption via demonstration projects. However, forward-looking statements caution that continued operations depend on future financing success, technological execution, and market acceptance — all subject to significant uncertainty. No guidance or revenue targets are provided, reinforcing the exploratory stage of commercialization.